Lidds AB Ownership
| LIDDS Stock | SEK 0.12 0.01 7.69% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Lidds |
Lidds Stock Ownership Analysis
About 19.0% of the company outstanding shares are owned by corporate insiders. The book value of Lidds AB was now reported as 0.72. The company recorded a loss per share of 1.1. Lidds AB had not issued any dividends in recent years. The entity had 326:303 split on the 17th of January 2023. LIDDS AB develops and sells pharmaceutical products for cancer and other diseases worldwide. It is developing various drugs, such as NZ-2HOF to treat prostate cancer NZ-DTX for lung cancer and solid tumors NZ-DOX for solid tumors NZ-IO, an antibody-based immunotherapy NZ-STING for immuno-oncology and NZ-BELINA for breast cancer. LIDDS AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. To find out more about Lidds AB contact the company at 46 00 44 55 66 or learn more at https://www.liddspharma.com.Lidds AB Outstanding Bonds
Lidds AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Lidds AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Lidds bonds can be classified according to their maturity, which is the date when Lidds AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Lidds Stock Analysis
When running Lidds AB's price analysis, check to measure Lidds AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lidds AB is operating at the current time. Most of Lidds AB's value examination focuses on studying past and present price action to predict the probability of Lidds AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lidds AB's price. Additionally, you may evaluate how the addition of Lidds AB to your portfolios can decrease your overall portfolio volatility.